First Manhattan CO Aquestive Therapeutics, Inc. Transaction History

First Manhattan CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $630 - $1,730	-1,000 Reduced 50.0%	1,000 $1,000
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $1,950 - $2,796	-600 Reduced 23.08%	2,000 $8,000
Q2 2021 Aug 16, 2021	BUY	$3.29 - $5.21 $8,554 - $13,546	2,600 New	2,600 $10,000
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $2,790 - $4,674	-600 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.12 - $9.09 $1,236 - $2,727	300 Added 100.0%	600 $2,000
Q2 2020 Aug 14, 2020	BUY	$1.84 - $6.44 $552 - $1,932	300 New	300 $1,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $243M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.